Literature DB >> 4055989

Urinary IgA in IgA nephropathy and Henoch-Schoenlein purpura.

J H Galla, M F Spotswood, L A Harrison, J Mestecky.   

Abstract

To determine the concentrations and molecular forms of urinary IgA in IgA nephropathy and Henoch-Schoenlein purpura, we studied 29 patients with these IgA-associated renal diseases (IgAN). Control groups comprised 10 patients with other diverse renal disease and 11 healthy volunteers. Urinary IgA and IgG concentrations were higher in IgAN than in either control group and correlated positively with the serum creatinine concentration as well as the urinary protein excretion (P less than 0.01). However, IgA/IgG ratios did not differ among the three groups. Polymeric IgA (p-IgA) in the urine predominated only in normals; in IgAN and patients with other renal diseases, monomeric IgA (m-IgA) occurred almost exclusively. Serum IgA concentrations were generally normal in IgAN; four patients had concentrations greater than 500 mg/dl. Although the fraction of p-IgA in serum (median, 18%) was increased above normal (5-10%) in 13 of 16 (81%) subjects, neither the concentration of IgA or IgG nor the amount of p-IgA correlated with the serum creatinine concentration. These data suggest that the molecular form and concentration of urinary IgA are not discriminating for IgAN and are independent of these characteristics of serum IgA.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4055989     DOI: 10.1007/BF00918248

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  28 in total

1.  IgA nephropathy.

Authors:  R C McCoy; C R Abramowsky; C C Tisher
Journal:  Am J Pathol       Date:  1974-07       Impact factor: 4.307

2.  The origin of monomeric and polymeric forms of IgA in man.

Authors:  J Radl; H R Schuit; J Mestecky; W Hijmans
Journal:  Adv Exp Med Biol       Date:  1974       Impact factor: 2.622

3.  Urinary immunoglobulins in healthy individuals and children with acute pyelonephritis.

Authors:  C Svanborg Edén; R Kulhavy; S Mårild; S J Prince; J Mestecky
Journal:  Scand J Immunol       Date:  1985-04       Impact factor: 3.487

4.  Occurrence of vascular IgA deposits in clinically normal skin of patients with renal disease.

Authors:  E H Faille-Kuyper; L Kater; R H Kuijten; C J Kooiker; S S Wagenaar; P van der Zouwen; E J Mees
Journal:  Kidney Int       Date:  1976-05       Impact factor: 10.612

Review 5.  The syndrome of IgA nephropathy.

Authors:  A R Clarkson; A J Woodroffe; K M Bannister; J D Lomax-Smith; I Aarons
Journal:  Clin Nephrol       Date:  1984-01       Impact factor: 0.975

6.  Serum complement proteins in IgA nephropathy.

Authors:  B A Julian; R J Wyatt; R G McMorrow; J H Galla
Journal:  Clin Nephrol       Date:  1983-11       Impact factor: 0.975

7.  Cross-reactivity of eluted antibodies from renal tissues of patients with henoch-Schönlein purpura nephritis and IgA nephropathy.

Authors:  Y Tomino; H Sakai; M Endoh; M Miura; T Suga; H Kaneshige; Y Nomoto
Journal:  Am J Nephrol       Date:  1983 Nov-Dec       Impact factor: 3.754

8.  IgA glomerulonephritis (Berger's disease): evidence of high serum levels of polymeric IgA.

Authors:  M L Trascasa; J Egido; J Sancho; L Hernando
Journal:  Clin Exp Immunol       Date:  1980-11       Impact factor: 4.330

9.  IgA-containing circulating immune complexes in dermatitis herpetiformis, Henoch-Schönlein purpura, systemic lupus erythematosus and other diseases.

Authors:  R P Hall; T J Lawley; J A Heck; S I Katz
Journal:  Clin Exp Immunol       Date:  1980-06       Impact factor: 4.330

10.  IgA-IgG nephropathy: predictive indices of progressive disease.

Authors:  S A Hood; J A Velosa; K E Holley; J V Donadio
Journal:  Clin Nephrol       Date:  1981-08       Impact factor: 0.975

View more
  5 in total

1.  Increased levels of serum IgA as IgA1 monomers in ankylosing spondylitis.

Authors:  H Hocini; S Iscaki; C Benlahrache; L Vitalis; X Chevalier; B Larget-Piet; J P Bouvet
Journal:  Ann Rheum Dis       Date:  1992-06       Impact factor: 19.103

2.  Sources of Urinary Proteins and their Analysis by Urinary Proteomics for the Detection of Biomarkers of Disease.

Authors:  Bruce A Julian; Hitoshi Suzuki; Yusuke Suzuki; Yasuhiko Tomino; Goce Spasovski; Jan Novak
Journal:  Proteomics Clin Appl       Date:  2009-08-26       Impact factor: 3.494

3.  Suppression of adiponectin by aberrantly glycosylated IgA1 in glomerular mesangial cells in vitro and in vivo.

Authors:  Tatsuyuki Inoue; Hitoshi Sugiyama; Masashi Kitagawa; Keiichi Takiue; Hiroshi Morinaga; Ayu Ogawa; Yoko Kikumoto; Shinji Kitamura; Yohei Maeshima; Hirofumi Makino
Journal:  PLoS One       Date:  2012-03-23       Impact factor: 3.240

Review 4.  Urinary biomarkers of IgA nephropathy and other IgA-associated renal diseases.

Authors:  Bruce A Julian; Stefan Wittke; Marion Haubitz; Petra Zürbig; Eric Schiffer; Brendan M McGuire; Robert J Wyatt; Jan Novak
Journal:  World J Urol       Date:  2007-07-10       Impact factor: 3.661

Review 5.  The Origin and Activities of IgA1-Containing Immune Complexes in IgA Nephropathy.

Authors:  Barbora Knoppova; Colin Reily; Nicolas Maillard; Dana V Rizk; Zina Moldoveanu; Jiri Mestecky; Milan Raska; Matthew B Renfrow; Bruce A Julian; Jan Novak
Journal:  Front Immunol       Date:  2016-04-12       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.